Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]

Oncodesign Services has expanded its collaboration with French research institute [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]

The UK is launching a major programme to convert used [...]

XenoSTART and Minerva Imaging have expanded their long-standing partnership to [...]

Telix Pharmaceuticals has reached agreement with the US Food and [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]

Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]

Orano Med has expanded its US research and development center [...]

Landmark debt deal enables commercial readiness for ITM-11, supports pipeline [...]